{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:40:46Z","timestamp":1760143246985,"version":"build-2065373602"},"reference-count":83,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>Richard Peto\u2019s paradox, first described in 1975 from an epidemiological perspective, established an inverse correlation between the probability of developing cancer in multicellular organisms and the number of cells. Larger animals exhibit fewer tumors compared to smaller ones, though exceptions exist. Mice are more susceptible to cancer than humans, while elephants and whales demonstrate significantly lower cancer prevalence rates than humans. How nature and evolution have addressed the issue of cancer in the animal kingdom remains largely unexplored. In the field of medicine, much attention has been devoted to cancer-predisposing genes, as they offer avenues for intervention, including blocking, downregulating, early diagnosis, and targeted treatment. Predisposing genes also tend to manifest clinically earlier and more aggressively, making them easier to identify. However, despite significant strides in modern medicine, the role of protective genes lags behind. Identifying genes with a mild predisposing effect poses a significant challenge. Consequently, comprehending the protective function conferred by genes becomes even more elusive, and their very existence is subject to questioning. While the role of variable expressivity and penetrance defects of the same variant in a family is well-documented for many hereditary cancer syndromes, attempts to delineate the function of protective\/modifier alleles have been restricted to a few instances. In this review, we endeavor to elucidate the role of protective genes observed in the animal kingdom, within certain genetic syndromes that appear to act as cancer-resistant\/repressor alleles. Additionally, we explore the role of protective alleles in conditions predisposing to cancer. The ultimate goal is to discern why individuals, like Winston Churchill, managed to live up to 91 years of age, despite engaging in minimal physical activity, consuming large quantities of alcohol daily, and not abstaining from smoking.<\/jats:p>","DOI":"10.3390\/genes15010118","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:28:46Z","timestamp":1705577326000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From Churchill to Elephants: The Role of Protective Genes against Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Annalisa","family":"Gazzellone","sequence":"first","affiliation":[{"name":"Sezione di Medicina Genomica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9079-9175","authenticated-orcid":false,"given":"Eugenio","family":"Sangiorgi","sequence":"additional","affiliation":[{"name":"Sezione di Medicina Genomica, Dipartimento di Scienze della Vita e Sanit\u00e0 Pubblica, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,18]]},"reference":[{"key":"ref_1","unstructured":"Lane, I.W., and Comac, L. (1992). Sharks Don\u2019t Get Cancer, Avery Pub Group. [1st ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/cncr.21107","article-title":"Evaluation of Shark Cartilage in Patients with Advanced Cancer: A North Central Cancer Treatment Group Trial","volume":"104","author":"Loprinzi","year":"2005","journal-title":"Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bjc.1975.242","article-title":"Cancer and Ageing in Mice and Men","volume":"32","author":"Peto","year":"1975","journal-title":"Br. J. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tollis, M., Boddy, A.M., and Maley, C.C. (2017). Peto\u2019s Paradox: How Has Evolution Solved the Problem of Cancer Prevention?. BMC Biol., 15.","DOI":"10.1186\/s12915-017-0401-7"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.7939630","article-title":"BRCA1 Mutations in Primary Breast and Ovarian Carcinomas","volume":"266","author":"Futreal","year":"1994","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrc1431","article-title":"BRCA1 and BRCA2: 1994 and Beyond","volume":"4","author":"Narod","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garutti, M., Foffano, L., Mazzeo, R., Michelotti, A., Da Ros, L., Viel, A., Miolo, G., Zambelli, A., and Puglisi, F. (2023). Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. Genes, 14.","DOI":"10.3390\/genes14051025"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nrg4017","article-title":"Protective Alleles and Modifier Variants in Human Health and Disease","volume":"16","author":"Harper","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/ng1006-1095","article-title":"The Genetics of Health","volume":"38","author":"Nadeau","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical Efficacy and Safety of Achieving Very Low LDL-Cholesterol Concentrations with the PCSK9 Inhibitor Evolocumab: A Prespecified Secondary Analysis of the FOURIER Trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1126\/science.aac8624","article-title":"Health and Population Effects of Rare Gene Knockouts in Adult Humans with Related Parents","volume":"352","author":"Narasimhan","year":"2016","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature22034","article-title":"Human Knockouts and Phenotypic Analysis in a Cohort with a High Rate of Consanguinity","volume":"544","author":"Saleheen","year":"2017","journal-title":"Nature"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.scib.2023.09.041","article-title":"Global, Regional, and National Lifetime Probabilities of Developing Cancer in 2020","volume":"68","author":"Zheng","year":"2023","journal-title":"Sci. Bull."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6112","DOI":"10.1093\/hmg\/ddu312","article-title":"Most Common \u201csporadic\u201d Cancers Have a Significant Germline Genetic Component","volume":"23","author":"Lu","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/postgradmedj-2020-139391","article-title":"Winston Churchill and His Illnesses","volume":"97","author":"Launer","year":"2021","journal-title":"Postgrad. Med. J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"574857","DOI":"10.3389\/fped.2020.574857","article-title":"Overgrowth Syndromes-Evaluation, Diagnosis, and Management","volume":"8","author":"Manor","year":"2020","journal-title":"Front. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"(2023, October 30). Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk|Clinical Cancer Research|American Association for Cancer Research. Available online: https:\/\/aacrjournals.org\/clincancerres\/article\/23\/12\/e83\/80230\/Recommendations-for-Cancer-Surveillance-in.","DOI":"10.1158\/1078-0432.CCR-17-0631"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tamura, R. (2021). Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115850"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/ajmg.a.40637","article-title":"What Is New with 22q? An Update from the 22q and You Center at the Children\u2019s Hospital of Philadelphia","volume":"176","author":"Campbell","year":"2018","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/gim.2016.23","article-title":"Low Risk of Solid Tumors in Persons with Down Syndrome","volume":"18","author":"Hasle","year":"2016","journal-title":"Genet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Dey, N., Krie, A., Klein, J., Williams, K., McMillan, A., Elsey, R., Sun, Y., Williams, C., De, P., and Leyland-Jones, B. (2017). Down\u2019s Syndrome and Triple Negative Breast Cancer: A Rare Occurrence of Distinctive Clinical Relationship. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061218"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc3355","article-title":"Tumorigenesis in Down\u2019s Syndrome: Big Lessons from a Small Chromosome","volume":"12","author":"Groet","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0969-9961(03)00107-4","article-title":"Overexpression of the Chromosome 21 Transcription Factor Ets2 Induces Neuronal Apoptosis","volume":"14","author":"Wolvetang","year":"2003","journal-title":"Neurobiol. Dis."},{"key":"ref_26","first-page":"211","article-title":"Trisomy 21 and Breast Cancer: A Genetic Abnormality Which Protects against Breast Cancer?","volume":"44","author":"Cordier","year":"2016","journal-title":"Gynecol. Obstet. Fertil."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature06446","article-title":"Trisomy Represses Apc(Min)-Mediated Tumours in Mouse Models of Down\u2019s Syndrome","volume":"451","author":"Sussan","year":"2008","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4614-0653-2_22","article-title":"Oxidative Stress and Mitochondrial Dysfunction in Down Syndrome","volume":"724","author":"Pagano","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.lfs.2004.10.026","article-title":"Anti-Oxidant Gene Expression Imbalance, Aging and Down Syndrome","volume":"76","author":"Sinha","year":"2005","journal-title":"Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2217\/fon.09.88","article-title":"Down\u2019s Syndrome: Protection against Cancer and the Therapeutic Potential of DSCR1","volume":"5","author":"Ryeom","year":"2009","journal-title":"Future Oncol."},{"key":"ref_31","unstructured":"(2023, December 21). High Serum Endostatin Levels in Down Syndrome: Implications for Improved Treatment and Prevention of Solid Tumours, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/11781696\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-7091-6721-2_11","article-title":"The MNB\/DYRK1A Protein Kinase: Neurobiological Functions and Down Syndrome Implications","volume":"67","author":"Elizalde","year":"2003","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI60455","article-title":"Increased Dosage of the Chromosome 21 Ortholog Dyrk1a Promotes Megakaryoblastic Leukemia in a Murine Model of Down Syndrome","volume":"122","author":"Malinge","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","article-title":"NFAT Dysregulation by Increased Dosage of DSCR1 and DYRK1A on Chromosome 21","volume":"441","author":"Arron","year":"2006","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.celrep.2018.04.008","article-title":"DYRK1A Kinase Positively Regulates Angiogenic Responses in Endothelial Cells","volume":"23","author":"Rozen","year":"2018","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"31895","DOI":"10.1074\/jbc.M110.147520","article-title":"Dyrk1A Phosphorylates P53 and Inhibits Proliferation of Embryonic Neuronal Cells","volume":"285","author":"Park","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1101\/gad.2034211","article-title":"DYRK1A Protein Kinase Promotes Quiescence and Senescence through DREAM Complex Assembly","volume":"25","author":"Litovchick","year":"2011","journal-title":"Genes. Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","article-title":"Dyrk1A Influences Neuronal Morphogenesis through Regulation of Cytoskeletal Dynamics in Mammalian Cortical Neurons","volume":"22","author":"Calvo","year":"2012","journal-title":"Cereb. Cortex"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","article-title":"Dyrk1A Haploinsufficiency Affects Viability and Causes Developmental Delay and Abnormal Brain Morphology in Mice","volume":"22","author":"Fotaki","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pbr.2019.09.002","article-title":"Genetic and Epigenetic Pathways in Down Syndrome: Insights to the Brain and Immune System from Humans and Mouse Models","volume":"251","author":"Yu","year":"2020","journal-title":"Prog. Brain Res."},{"key":"ref_41","first-page":"11","article-title":"Down Syndrome and MicroRNAs","volume":"8","author":"Rodrigues","year":"2018","journal-title":"Biomed. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"153657","DOI":"10.1155\/2010\/153657","article-title":"Effects of S100B on Serotonergic Plasticity and Neuroinflammation in the Hippocampus in Down Syndrome and Alzheimer\u2019s Disease: Studies in an S100B Overexpressing Mouse Model","volume":"2010","author":"Shapiro","year":"2010","journal-title":"Cardiovasc. Psychiatry Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103783","DOI":"10.1016\/j.ejmg.2019.103783","article-title":"Cancer Screening in Adults with down Syndrome, a Proposal","volume":"63","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrurol.2009.127","article-title":"ETS Gene Fusions in Prostate Cancer","volume":"6","author":"Clark","year":"2009","journal-title":"Nat. Rev. Urol."},{"key":"ref_45","first-page":"1247","article-title":"Syndrome of Familial Dwarfism and High Plasma Immunoreactive Growth Hormone","volume":"10","author":"Laron","year":"1974","journal-title":"Isr. J. Med. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJM198910123211501","article-title":"Laron Dwarfism and Mutations of the Growth Hormone-Receptor Gene","volume":"321","author":"Amselem","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ghir.2006.10.007","article-title":"Patients with Congenital Deficiency of IGF-I Seem Protected from the Development of Malignancies: A Preliminary Report","volume":"17","author":"Shevah","year":"2007","journal-title":"Growth Horm. IGF Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2010.171","article-title":"Growth Hormone, the Insulin-like Growth Factor Axis, Insulin and Cancer Risk","volume":"7","author":"Clayton","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_49","first-page":"70ra13","article-title":"Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans","volume":"3","author":"Balasubramanian","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Werner, H., Lapkina-Gendler, L., Achlaug, L., Nagaraj, K., Somri, L., Yaron-Saminsky, D., Pasmanik-Chor, M., Sarfstein, R., Laron, Z., and Yakar, S. (2019). Genome-Wide Profiling of Laron Syndrome Patients Identifies Novel Cancer Protection Pathways. Cells, 8.","DOI":"10.3390\/cells8060596"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ghir.2017.11.004","article-title":"Differential Expression of IGFBPs in Laron Syndrome-Derived Lymphoblastoid Cell Lines: Potential Correlation with Reduced Cancer Incidence","volume":"39","author":"Somri","year":"2018","journal-title":"Growth Horm. IGF Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1126\/science.1121908","article-title":"Mutations That Increase the Life Span of C. Elegans Inhibit Tumor Growth","volume":"313","author":"Pinkston","year":"2006","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.2.6.678","article-title":"Mechanisms by Which IGF-I May Promote Cancer","volume":"2","author":"Grimberg","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"13215","DOI":"10.1073\/pnas.94.24.13215","article-title":"A Mammalian Model for Laron Syndrome Produced by Targeted Disruption of the Mouse Growth Hormone Receptor\/Binding Protein Gene (the Laron Mouse)","volume":"94","author":"Zhou","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13058-015-0518-y","article-title":"Mammary Gland Tumor Promotion by Chronic Administration of IGF1 and the Insulin Analogue AspB10 in the P53R270H\/+WAPCre Mouse Model","volume":"17","author":"Siezen","year":"2015","journal-title":"Breast Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"bqac174","DOI":"10.1210\/endocr\/bqac174","article-title":"Mammary Tumor Growth and Proliferation Are Dependent on Growth Hormone in Female SV40 C3(1) T-Antigen Mice","volume":"164","author":"Unterberger","year":"2022","journal-title":"Endocrinology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1038\/s41388-022-02376-w","article-title":"IGF1R Acts as a Cancer-Promoting Factor in the Tumor Microenvironment Facilitating Lung Metastasis Implantation and Progression","volume":"41","author":"Canalejo","year":"2022","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Nobile, V., Pucci, C., Chiurazzi, P., Neri, G., and Tabolacci, E. (2021). DNA Methylation, Mechanisms of FMR1 Inactivation and Therapeutic Perspectives for Fragile X Syndrome. Biomolecules, 11.","DOI":"10.3390\/biom11020296"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/ajmg.1533","article-title":"Evidence of Decreased Risk of Cancer in Individuals with Fragile X","volume":"103","author":"Hasle","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2788.2008.01116.x","article-title":"Cancer Incidence among Persons with Fragile X Syndrome in Finland: A Population-Based Study","volume":"53","author":"Sund","year":"2009","journal-title":"J. Intellect. Disabil. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/emmm.201302847","article-title":"The Fragile X Protein Binds MRNAs Involved in Cancer Progression and Modulates Metastasis Formation","volume":"5","author":"Averna","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_62","unstructured":"(2023, October 30). Gene Expression Profiling Identifies WNT7A as a Possible Candidate Gene for Decreased Cancer Risk in Fragile X Syndrome Patients, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/20470940\/."},{"key":"ref_63","first-page":"209","article-title":"Reduced Cancer Incidence in Huntington\u2019s Disease: Analysis in the Registry Study","volume":"7","author":"McNulty","year":"2018","journal-title":"J. Huntingtons Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/cge.12010","article-title":"Reduced Cancer Incidence in Huntington\u2019s Disease: Record Linkage Study Clue to an Evolutionary Trade-Off?","volume":"83","author":"Turner","year":"2013","journal-title":"Clin. Genet."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugalcdep.2006.06.009","article-title":"Huntington Disease as a Dual Diagnosis Disorder: Data from the National Research Roster for Huntington Disease Patients and Families","volume":"86","author":"Ehret","year":"2007","journal-title":"Drug Alcohol. Depend."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ejhg.2016.13","article-title":"CAG Repeat Size in Huntingtin Alleles Is Associated with Cancer Prognosis","volume":"24","author":"Thion","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e45336","DOI":"10.15252\/embr.201745336","article-title":"Small Interfering RNAs Based on Huntingtin Trinucleotide Repeats Are Highly Toxic to Cancer Cells","volume":"19","author":"Murmann","year":"2018","journal-title":"EMBO Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5280","DOI":"10.21037\/tcr-21-1257","article-title":"ADRB2 Is a Potential Protective Gene in Breast Cancer by Regulating Tumor Immune Microenvironment","volume":"10","author":"Wei","year":"2021","journal-title":"Transl. Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/1878-0261.12665","article-title":"The RAD52 S346X Variant Reduces Risk of Developing Breast Cancer in Carriers of Pathogenic Germline BRCA2 Mutations","volume":"14","author":"Adamson","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/1878-0261.12679","article-title":"RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers","volume":"14","author":"Biswas","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1001\/jama.2015.13134","article-title":"Potential Mechanisms for Cancer Resistance in Elephants and Comparative Cellular Response to DNA Damage in Humans","volume":"314","author":"Abegglen","year":"2015","journal-title":"JAMA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.celrep.2018.07.042","article-title":"A Zombie LIF Gene in Elephants Is Upregulated by TP53 to Induce Apoptosis in Response to DNA Damage","volume":"24","author":"Vazquez","year":"2018","journal-title":"Cell Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Padariya, M., Jooste, M.-L., Hupp, T., F\u00e5hraeus, R., Vojtesek, B., Vollrath, F., Kalathiya, U., and Karakostis, K. (2022). The Elephant Evolved P53 Isoforms That Escape MDM2-Mediated Repression and Cancer. Mol. Biol. Evol., 39.","DOI":"10.1093\/molbev\/msac149"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2017.01.016","article-title":"Biological and Predictive Role of ERCC1 Polymorphisms in Cancer","volume":"111","author":"Formica","year":"2017","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.celrep.2014.12.008","article-title":"Insights into the Evolution of Longevity from the Bowhead Whale Genome","volume":"10","author":"Keane","year":"2015","journal-title":"Cell Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nature00991","article-title":"RAD6-Dependent DNA Repair Is Linked to Modification of PCNA by Ubiquitin and SUMO","volume":"419","author":"Hoege","year":"2002","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0047-6374(96)01802-7","article-title":"Age-Related Changes in Proliferating Cell Nuclear Antigen Levels","volume":"92","author":"Tanno","year":"1996","journal-title":"Mech. Ageing Dev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11357-008-9053-4","article-title":"Rodents for Comparative Aging Studies: From Mice to Beavers","volume":"30","author":"Gorbunova","year":"2008","journal-title":"Age"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12234","article-title":"High-Molecular-Mass Hyaluronan Mediates the Cancer Resistance of the Naked Mole Rat","volume":"499","author":"Tian","year":"2013","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"113130","DOI":"10.1016\/j.celrep.2023.113130","article-title":"CD44 Correlates with Longevity and Enhances Basal ATF6 Activity and ER Stress Resistance","volume":"42","author":"Takasugi","year":"2023","journal-title":"Cell Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1073\/pnas.1418203112","article-title":"INK4 Locus of the Tumor-Resistant Rodent, the Naked Mole Rat, Expresses a Functional P15\/P16 Hybrid Isoform","volume":"112","author":"Tian","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41586-023-06463-0","article-title":"Increased Hyaluronan by Naked Mole-Rat Has2 Improves Healthspan in Mice","volume":"621","author":"Zhang","year":"2023","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ccr.2004.07.009","article-title":"Species- and Cell Type-Specific Requirements for Cellular Transformation","volume":"6","author":"Rangarajan","year":"2004","journal-title":"Cancer Cell"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/1\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:49:46Z","timestamp":1760104186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/15\/1\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["genes15010118"],"URL":"https:\/\/doi.org\/10.3390\/genes15010118","relation":{},"ISSN":["2073-4425"],"issn-type":[{"type":"electronic","value":"2073-4425"}],"subject":[],"published":{"date-parts":[[2024,1,18]]}}}